bpc-157 fda warning not approved unapproved drug safety fda bpc-157 peptide approved bpc-157 bpc-157 fda warning not approved

Most research-supply guidance keeps reconstituted vials usable for about 3-4 weeks

Immediately after she began treatment with this combination of peptides, the pain she had experienced for more than six months began to subside

My next-door neighbor called this afternoon telling me that her doctor won't renew her prescription

Research on the different mast cell disorders dates back decades

I began treating more patients who had oral mucositis with methylene blue

Day 2 backed Epitalon and Semax but rejected Emideltide The FDA peptide vote 2026 ended with six favorable peptide-level recommendations and one unfavorable recommendation